New pain relief combo aims to get bowels moving faster after surgery
NCT ID NCT07651722
First seen Jun 17, 2026 · Last updated Jun 22, 2026 · Updated 1 time
Summary
This study tests whether a combination of a long-acting numbing drug (liposomal bupivacaine) injected into the abdominal wall and a painkiller (oxycodone) given through an IV can help the gut recover faster after major abdominal surgery. The trial will enroll 132 adults having small bowel or colorectal surgery. Participants will be split into three groups to compare different pain relief methods, with the main goal being better bowel function in the first week after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Tianjin First Central Hospital
Tianjin, Tianjin Municipality, 300384, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
liposomal bupivacaine and oxycodone
What this could lead to
If it works, this could lead to a standard pain management approach that helps patients recover bowel function faster after abdominal surgery.
What could go wrong
This is a small, early-stage trial that hasn't started yet. The new combination may not work better than existing options, and any painkiller carries risks like nausea or breathing problems.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.